etravirine
- Product NDC
- 69238-1720
- 11-digit product format
- 692381720
- Labeler code
- 69238
- Product ID
- 69238-1720_2ea1c501-299b-4bea-97d6-d0c695d58271
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- etravirine
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Amneal Pharmaceuticals NY LLC
- Application
- ANDA214196
- Marketing category
- ANDA
- Marketing start
- 2021-06-14
- Marketing end
- 0000-00-00
- Substance
- ETRAVIRINE
- Active strength
- 25 mg/1
- Pharmacologic classes
- Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A Inducers [MoA], Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Non-Nucleoside Analog [EXT], Non-Nucleoside Reverse Transcriptase Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 69238-1720 | ETRAVIRINE TABLET [AMNEAL PHARMACEUTICALS NY LLC] | 2 | Legacy NDC | 20231231_f6430b98-b521-46e5-af98-b1d9b128d1f9.zip |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 69238-1720-7 | 69238172007 | 120 TABLET in 1 BOTTLE, PLASTIC (69238-1720-7) | 120 tablet | 2021-06-14 | 0000-00-00 | No | No | Current |